Objective: To probe into the clinical treatment practice for children with chronic active Epstein-Barr virus infection by clinical pharmacists. Methods: Clinical pharmacists participated into the treatment for one child with chronic active Epstein-Barr virus infection. By reviewing relevant treatment guidelines and literature reviews

clinical pharmacists assisted clinicians to improve the treatment regimen and monitor the initial treatment

selection of drugs during induction period and adverse drug reactions of chemotherapy. Results: The child’s condition was effectively controlled without the occurrence of adverse drug reactions such as re-induction of treatment

bone marrow suppression and severe infections induced by reactivation of Epstein-Barr virus immunity. After two chemotherapy sessions

the child was in stable condition and was transferred to the specialist hospital for allogeneic hematopoietic stem cell transplantation. Conclusion: Clinical pharmacists give full play to the professional advantages in clinic

which have positive significance for the safe

effective and rational use of drugs for chronic active Epstein-Barr virus infection in children